Axios on MSN3h
The weight loss drug revolution is shrinking America's waistline
Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
Top GP warns NHS waiting list is driving rise in unsafe fat jabs and backstreet dealers
Prof Kamila Hawthorne, chairwoman of the Royal College of GPs, warned people are putting themselves at risk by buying ...
Daily9d
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market
Pfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Hosted on MSN11d
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
STAT12d
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...
Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...
san9d
1 in 6 skipping their weight loss injections for the holidays
AND ON TOP OF THE LIST OF HOLIDAY TEMPTATIONS ... EVEN UNDER A DOCTOR’S SUPERVISION WEIGHT LOSS INJECTIONS ARE KNOWN FOR THEIR UNPLEASEANT SIDE EFFECTS – ESPECIALLY GASTROINTESTINAL ISSUES. KEEP UP ...
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli ...